How to sense-check prescriber oversight

Why prescriber oversight matters

In a private weight-management service, a prescriber is making clinical decisions about your care. The quality of that oversight — how thoroughly your health is assessed, how regularly treatment is reviewed, and what happens if something changes — directly affects your safety.

Some services describe a “doctor-led” or “clinician-reviewed” process without clarifying what that actually involves. These questions help you distinguish structured oversight from marketing language.

Questions about who prescribes

• Is the prescriber a named individual whose registration you can check on a public register (GMC, GPhC, or NMC)?
• Does the service clearly state whether the prescriber is a doctor, pharmacist independent prescriber, or nurse independent prescriber?
• Is there a named clinical lead, superintendent pharmacist, or medical director responsible for clinical governance?

Questions about the initial assessment

• Does the service ask about your medical history, current medications, and relevant conditions before prescribing?
• Is the consultation described as a medical assessment, or does it feel more like a checkout page?
• Are there clear criteria that might result in the service declining to prescribe?
• Does the service explain what happens if you are not suitable — for example, a referral back to your GP?

Questions about ongoing review

• How often are follow-up reviews conducted, and are they clinical reviews or automated check-ins?
• Can you speak to a prescriber or clinician between scheduled reviews if your situation changes?
• Does the service monitor progress (for example, weight trends or side-effect reporting) and adjust the plan accordingly?
• Is there a clear process for pausing or stopping treatment if it is not appropriate to continue?

Questions about escalation

• What happens if you experience a serious side effect outside of business hours?
• Does the service provide a direct escalation route, or are you directed to NHS 111 or A&E by default?
• Is there a process for communicating with your GP about ongoing treatment?

What good oversight looks like

• Named, verifiable prescribers with clear registration details.
• An initial assessment that checks for contraindications and may decline to prescribe.
• Scheduled clinical reviews with a process for adjusting or stopping treatment.
• A transparent escalation route for urgent concerns.
• Communication pathways to your own GP.

Compare these signals across providers using our provider directory and the evaluation rubric.

Next steps

• Check general eligibility criteria
• Browse the provider directory
• See how we evaluate providers

Last reviewed: March 2026

Sources

• General Medical Council — Prescribing guidance
• General Pharmaceutical Council — Standards
• How we evaluate providers